{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:52:56Z","timestamp":1785901976950,"version":"3.56.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Regional Research Council Mid Sweden","award":["RFR-554761, RFR-383651, RFR-307661, RFR-940344, RFR-968825"],"award-info":[{"award-number":["RFR-554761, RFR-383651, RFR-307661, RFR-940344, RFR-968825"]}]},{"name":"Swedish Heart and Lung Foundation","award":["20230587, 20200174, 20170673"],"award-info":[{"award-number":["20230587, 20200174, 20170673"]}]},{"DOI":"10.13039\/100018870","name":"Swedish Heart and Lung Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018870","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["VR 2020-02008"],"award-info":[{"award-number":["VR 2020-02008"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100018853","name":"Uppsala County Association against Heart and Lung Diseases","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018853","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100020034","name":"Bror Hjerpstedt Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100020034","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Centre for Research and Development, Uppsala University\/Region G\u00e4vleborg","award":["CFUG-700231, CFUG-966304, CFUG-966654, CFUG-973672"],"award-info":[{"award-number":["CFUG-700231, CFUG-966304, CFUG-966654, CFUG-973672"]}]},{"name":"Centre for Clinical Research, Uppsala University, County Council Dalarna","award":["CKFUU-1000499, CKFUU-511451, CKFUU-600721, CKFUU-701041, CKFUU-975124"],"award-info":[{"award-number":["CKFUU-1000499, CKFUU-511451, CKFUU-600721, CKFUU-701041, CKFUU-975124"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Prim. Care Respir. Med."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Whether COPD should be diagnosed using the lower limit of normal (LLN) or a fixed FEV\n                    <jats:sub>1<\/jats:sub>\n                    \/FVC ratio &lt;0.70 (FR) is debated. We compared symptom and disease burden in COPD patients with FEV\u2081\/FVC below both thresholds (FR\u2009+\u2009\/LLN\u2009+\u2009) versus those between them (FR\u2009+\u2009\/LLN-). This cohort study included 572 COPD patients from primary and secondary care in the central Swedish regions of Dalarna, G\u00e4vleborg, and Uppsala. FR\u2009+\u2009\/LLN\u2009+\u2009COPD patients with FEV\n                    <jats:sub>1<\/jats:sub>\n                    \u2009\u2265\u200960% predicted (n\u2009=\u2009194) was compared to FR\u2009+\u2009\/LLN- COPD patients (n\u2009=\u200985) in order to have similar FEV\n                    <jats:sub>1<\/jats:sub>\n                    levels in both groups. The symptom burden was assessed using the modified British Medical Research Council scale of dyspnoea (mMRC), the COPD Assessment Test (CAT), and the Clinical COPD Questionnaire (CCQ). The disease burden was assessed by exacerbations and hospital admissions over the subsequent three years. The 279 studied patients (57% females) had a mean age of 68.2 years and a mean FEV\n                    <jats:sub>1<\/jats:sub>\n                    % predicted of 73.0%. The FR\u2009+\u2009\/LLN+ group had comparable clinical characteristics to the FR\u2009+\u2009\/LLN- group regarding FEV\n                    <jats:sub>1<\/jats:sub>\n                    % predicted (72.5 vs 74.2%), use of inhaled medicines (76.3 vs 76.5%), and previous exacerbations (23.2 vs 18.8%), all p-values\u2009&gt;\u20090.05. Moreover, comparable prevalence of exacerbations and hospital admissions were found during the subsequent three years (31.7 vs 37.7%, and 4.8 vs 2.6%, respectively, all p-values\u2009&gt;\u20090.05). Symptom burden was comparable for mMRC and CCQ, but the FR\u2009+\u2009\/LLN- group had a higher CAT score than the FR\u2009+\u2009\/LLN+ group (10.6 vs 12.6, p\u2009=\u20090.038), a finding also confirmed in adjusted analyses. FR\u2009+\u2009\/LLN+ and FR\u2009+\u2009\/LLN- COPD patients had relatively comparable symptom and disease burden, suggesting that not meeting the LLN criteria does not indicate a milder disease in clinically diagnosed COPD with comparable FEV\n                    <jats:sub>1<\/jats:sub>\n                    .\n                  <\/jats:p>","DOI":"10.1038\/s41533-025-00478-y","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T20:52:29Z","timestamp":1767905549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Health status and prognosis of COPD patients in relation to the FEV1\/FVC ratio"],"prefix":"10.1038","volume":"36","author":[{"given":"Juan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"St\u00e4llberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"H\u00e5rdstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Br\u00f6ms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Farkhooy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Palm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Lisspers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieann","family":"H\u00f6gman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Malinovschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"478_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-069679","volume":"378","author":"S Safiri","year":"2022","unstructured":"Safiri, S. et al. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019. Bmj 378, e069679 (2022).","journal-title":"Bmj"},{"key":"478_CR2","unstructured":"Global Initiative for Chronic Obstructive Lung Disease 2023 Report. https:\/\/goldcopd.org\/2023-gold-report-2\/ (2023)."},{"key":"478_CR3","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1136\/thx.2008.098483","volume":"63","author":"MP Swanney","year":"2008","unstructured":"Swanney, M. P. et al. Using the lower limit of normal for the FEV1\/FVC ratio reduces the misclassification of airway obstruction. Thorax 63, 1046\u20131051 (2008).","journal-title":"Thorax"},{"key":"478_CR4","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.4187\/respcare.01160","volume":"56","author":"AN Aggarwal","year":"2011","unstructured":"Aggarwal, A. N., Gupta, D., Agarwal, R. & Jindal, S. K. Comparison of the lower confidence limit to the fixed-percentage method for assessing airway obstruction in routine clinical practice. Respir. Care 56, 1778\u20131784 (2011).","journal-title":"Respir. Care"},{"key":"478_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.rmed.2018.04.011","volume":"139","author":"S Liu","year":"2018","unstructured":"Liu, S. et al. Clinical impact of the lower limit of normal of FEV(1)\/FVC on detecting chronic obstructive pulmonary disease: a follow-up study based on cross-sectional data. Respir. Med. 139, 27\u201333 (2018).","journal-title":"Respir. Med."},{"key":"478_CR6","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.3760\/cma.j.issn.0366-6999.20130801","volume":"126","author":"Y Wang","year":"2013","unstructured":"Wang, Y., Xiao, W., Ma, D. D. & Jiang, Y. Y. Predicted lower limit of normal reduces misclassification risk of airflow limitation in asymptomatic elderly never-smokers. Chin. Med. J. 126, 3486\u20133492 (2013).","journal-title":"Chin. Med. J."},{"key":"478_CR7","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.rmed.2013.06.016","volume":"107","author":"P Wollmer","year":"2013","unstructured":"Wollmer, P. & Engstr\u00f6m, G. Fixed ratio or lower limit of normal as cut-off value for FEV1\/VC: an outcome study. Respir. Med. 107, 1460\u20131462 (2013).","journal-title":"Respir. Med."},{"key":"478_CR8","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S2213-2600(21)00511-7","volume":"10","author":"D Adeloye","year":"2022","unstructured":"Adeloye, D. et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir. Med. 10, 447\u2013458 (2022).","journal-title":"Lancet Respir. Med."},{"key":"478_CR9","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1183\/09031936.00080312","volume":"40","author":"PH Quanjer","year":"2012","unstructured":"Quanjer, P. H. et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur. Respir. J. 40, 1324\u20131343 (2012).","journal-title":"Eur. Respir. J."},{"key":"478_CR10","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1164\/rccm.202205-0963OC","volume":"207","author":"C Bowerman","year":"2023","unstructured":"Bowerman, C. et al. A race-neutral approach to the interpretation of lung function measurements. Am. J. Respir. Crit. Care Med. 207, 768\u2013774 (2023).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"478_CR11","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1183\/09031936.05.00035205","volume":"26","author":"R Pellegrino","year":"2005","unstructured":"Pellegrino, R. et al. Interpretative strategies for lung function tests. Eur. Respir. J. 26, 948\u2013968 (2005).","journal-title":"Eur. Respir. J."},{"key":"478_CR12","doi-asserted-by":"publisher","first-page":"603","DOI":"10.4187\/respcare.07069","volume":"65","author":"L Ma","year":"2020","unstructured":"Ma, L. et al. Fixed ratio versus lower limit of normal: health status and risk factors for COPD overdiagnosis. Respir. Care 65, 603\u2013609 (2020).","journal-title":"Respir. Care"},{"key":"478_CR13","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.2147\/COPD.S146914","volume":"13","author":"MR Miller","year":"2018","unstructured":"Miller, M. R. et al. Clinical characteristics of patients newly diagnosed with COPD by the fixed ratio and lower limit of normal criteria: a cross-sectional analysis of the TargetCOPD trial. Int. J. Chron. Obstruct Pulmon Dis. 13, 1979\u20131986 (2018).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"478_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/cpf.12294","volume":"37","author":"P Wollmer","year":"2017","unstructured":"Wollmer, P. et al. Fixed ratio or lower limit of normal for the FEV(1) \/VC ratio: relation to symptoms and extended lung function tests. Clin. Physiol. Funct. Imaging 37, 263\u2013269 (2017).","journal-title":"Clin. Physiol. Funct. Imaging"},{"key":"478_CR15","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.2147\/COPD.S250720","volume":"15","author":"M Llord\u00e9s","year":"2020","unstructured":"Llord\u00e9s, M. et al. Fixed ratio versus lower limit of normality for diagnosing COPD in primary care: Long-Term Follow-Up of EGARPOC Study. Int. J. Chron. Obstruct Pulmon Dis. 15, 1403\u20131413 (2020).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"478_CR16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1513\/AnnalsATS.201703-194OC","volume":"15","author":"PMA Calverley","year":"2018","unstructured":"Calverley, P. M. A., Mueller, A., Fowler, A., Metzdorf, N. & Wise, R. A. The effect of defining chronic obstructive pulmonary disease by the lower limit of normal of FEV(1)\/FVC ratio in tiotropium safety and performance in respimat participants. Ann. Am. Thorac. Soc. 15, 200\u2013208 (2018).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"478_CR17","volume":"47","author":"M Grafino","year":"2022","unstructured":"Grafino, M. et al. Spirometry for the diagnosis of airway obstruction in patients with risk factors for COPD: the GOLD and lower limit of normal criteria. J. Bras. Pneumol. 47, e20210124 (2022).","journal-title":"J. Bras. Pneumol."},{"key":"478_CR18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2147\/COPD.S151016","volume":"13","author":"M H\u00f6gman","year":"2018","unstructured":"H\u00f6gman, M. et al. 2017 global initiative for chronic obstructive lung disease reclassifies half of COPD subjects to lower risk group. Int. J. Chron. Obstruct Pulmon Dis. 13, 165\u2013173 (2018).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"478_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller, M. R. et al. Standardisation of spirometry. Eur. Respir. J. 26, 319\u2013338 (2005).","journal-title":"Eur. Respir. J."},{"key":"478_CR20","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1183\/09031936.98.12020363","volume":"12","author":"JA Wedzicha","year":"1998","unstructured":"Wedzicha, J. A. et al. Randomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale. Eur. Respir. J. 12, 363\u2013369 (1998).","journal-title":"Eur. Respir. J."},{"key":"478_CR21","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1164\/arrd.1987.135.6.1229","volume":"135","author":"DA Mahler","year":"1987","unstructured":"Mahler, D. A. et al. Comparison of clinical dyspnea ratings and psychophysical measurements of respiratory sensation in obstructive airway disease. Am. Rev. Respir. Dis. 135, 1229\u20131233 (1987).","journal-title":"Am. Rev. Respir. Dis."},{"key":"478_CR22","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1183\/09031936.00102509","volume":"34","author":"PW Jones","year":"2009","unstructured":"Jones, P. W. et al. Development and first validation of the COPD Assessment Test. Eur. Respir. J. 34, 648\u2013654 (2009).","journal-title":"Eur. Respir. J."},{"key":"478_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1477-7525-1-13","volume":"1","author":"T van der Molen","year":"2003","unstructured":"van der Molen, T. et al. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual. Life Outcomes 1, 13 (2003).","journal-title":"Health Qual. Life Outcomes"},{"key":"478_CR24","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.3390\/jcm13133855","volume":"13","author":"J Ellingsen","year":"2024","unstructured":"Ellingsen, J. et al. CRP, fibrinogen, white blood cells, and blood cell indices as prognostic biomarkers of future COPD exacerbation frequency: the TIE cohort study. J. Clin. Med. 13, 3855 (2024).","journal-title":"J. Clin. Med."},{"key":"478_CR25","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1164\/rccm.200406-710ST","volume":"171","author":"American Thoracic Society; European Respiratory Society","year":"2005","unstructured":"American Thoracic Society; European Respiratory Society ATS\/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am. J. Respir. Crit. Care Med. 171, 912\u2013930 (2005).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"478_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B, Methodol. 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Ser. B, Methodol."},{"key":"478_CR27","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.rmed.2011.06.012","volume":"105","author":"AS Afonso","year":"2011","unstructured":"Afonso, A. S., Verhamme, K. M., Sturkenboom, M. C. & Brusselle, G. G. COPD in the general population: prevalence, incidence and survival. Respir. Med. 105, 1872\u20131884 (2011).","journal-title":"Respir. Med."},{"key":"478_CR28","doi-asserted-by":"publisher","first-page":"h3021","DOI":"10.1136\/bmj.h3021","volume":"351","author":"MR Miller","year":"2015","unstructured":"Miller, M. R. & Levy, M. L. Chronic obstructive pulmonary disease: missed diagnosis versus misdiagnosis. Bmj 351, h3021 (2015).","journal-title":"Bmj"},{"key":"478_CR29","doi-asserted-by":"publisher","first-page":"927","DOI":"10.2147\/COPD.S104644","volume":"11","author":"K Tor\u00e9n","year":"2016","unstructured":"Tor\u00e9n, K. et al. Vital capacity and COPD: the Swedish CArdioPulmonary bioimage study (SCAPIS). Int. J. Chron. Obstruct Pulmon Dis. 11, 927\u2013933 (2016).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"478_CR30","doi-asserted-by":"publisher","first-page":"2356510","DOI":"10.1080\/15412555.2024.2356510","volume":"21","author":"A Penedones","year":"2024","unstructured":"Penedones, A. et al. Relationship between chronic obstructive pulmonary disease and osteoporosis: a scoping review. Copd 21, 2356510 (2024).","journal-title":"Copd"},{"key":"478_CR31","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4103\/jpbs.JPBS_126_19","volume":"11","author":"AN Bitar","year":"2019","unstructured":"Bitar, A. N., Syed Sulaiman, S. A., Ali, I. A. H., Khan, I. & Khan, A. H. Osteoporosis among patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of prevalence, severity, and therapeutic outcomes. J. Pharm. Bioallied Sci. 11, 310\u2013320 (2019).","journal-title":"J. Pharm. Bioallied Sci."},{"key":"478_CR32","doi-asserted-by":"publisher","first-page":"105249","DOI":"10.1016\/j.jbspin.2021.105249","volume":"89","author":"L Kakoullis","year":"2022","unstructured":"Kakoullis, L. et al. The impact of osteoporosis and vertebral compression fractures on mortality and association with pulmonary function in COPD: a meta-analysis. Jt. Bone Spine 89, 105249 (2022).","journal-title":"Jt. Bone Spine"}],"container-title":["npj Primary Care Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41533-025-00478-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-025-00478-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-025-00478-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:36:53Z","timestamp":1785901013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41533-025-00478-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["478"],"URL":"https:\/\/doi.org\/10.1038\/s41533-025-00478-y","relation":{},"ISSN":["2055-1010"],"issn-type":[{"value":"2055-1010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"6 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"4"}}